ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.
the classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field.
USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015.
North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country.
market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Enzyme-Linked Immunosorbent Assay (ELISA) market is valued at 160 million US$ in 2018 and will reach 210 million US$ by the end of 2025, growing at a CAGR of 3.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Enzyme-Linked Immunosorbent Assay (ELISA) market based on company, product type, end user and key regions.
This report studies the global market size of Enzyme-Linked Immunosorbent Assay (ELISA) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Enzyme-Linked Immunosorbent Assay (ELISA) in these regions.
This research report categorizes the global Enzyme-Linked Immunosorbent Assay (ELISA) market by top players/brands, region, type and end user. This report also studies the global Enzyme-Linked Immunosorbent Assay (ELISA) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Shenzhen YHLO Biotech
Market size by Product
ELISA Sets
ELISA Kits
Market size by End User
ELISA in HIV
ELISA in West Nile Virus
Detecting Antigens or Antibodies
Biodefense
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Enzyme-Linked Immunosorbent Assay (ELISA) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Enzyme-Linked Immunosorbent Assay (ELISA) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Enzyme-Linked Immunosorbent Assay (ELISA) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Enzyme-Linked Immunosorbent Assay (ELISA) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Enzyme-Linked Immunosorbent Assay (ELISA) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Enzyme-Linked Immunosorbent Assay (ELISA) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Enzyme-Linked Immunosorbent Assay (ELISA) . Industry analysis & Market Report on Enzyme-Linked Immunosorbent Assay (ELISA) is a syndicated market report, published as Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Enzyme-Linked Immunosorbent Assay (ELISA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.